Sonoma Pharmaceuticals Inc., of Petaluma, Calif., filed an S-1 to offer 7.3 million shares of common stock, together with warrants to purchase 3.65 million shares, in a unit-based offering. The unit price has not yet been disclosed. The specialty pharma said it will use net proceeds for general corporate purposes, new product launches and working capital.